About this Research Topic
Childhood myopia has emerged as a global public health concern, with its prevalence rapidly increasing worldwide. Myopia is typically diagnosed in early childhood and often progresses throughout adolescence. Severe myopia can lead to serious complications such as retinal detachment, glaucoma, and macular degeneration. A variety of factors contribute to the rising incidence, including increased screen time, reduced outdoor activities, genetic predispositions etc. Recent research has focused on identifying both preventive strategies and interventional treatments to prevent the progression of myopia in children, as delaying or halting progression could significantly reduce the burden of related complications in adulthood. The development and clinical application of new therapeutic modalities, such as pharmacological agents, optical interventions and environmental modifications, have shown promise. However, further exploration is necessary to optimize these approaches and establish comprehensive guidelines for both the prevention and management of childhood myopia.
The primary aim of this research topic is to address the growing challenge of childhood myopia and evaluate the efficacy of interventional modalities for both prevention and management. The goal is to gather high-quality research that presents novel strategies for controlling myopia progression, with a focus on interventions that can be implemented in early childhood. This includes evaluating various optical, pharmacological, and behavioural interventions, assessing their long-term impact, and understanding their potential in clinical practice. By examining these interventional strategies, this research hopes to provide clearer guidelines for healthcare professionals and policymakers to implement effective programs that reduce the prevalence and complications associated with childhood myopia. Ultimately, the aim is to contribute towards developing a more targeted and multidisciplinary approach to controlling the global myopia epidemic.
The scope of this research topic includes a wide range of interventional approaches for childhood myopia. We invite submissions that explore therapeutic modalities, including pharmacological treatments such as atropine eye drops; optical interventions like specialised spectacles, contact lenses, orthokeratology lenses and environmental strategies such as increased outdoor activity. Authors are encouraged to submit original research, reviews, meta-analyses, case reports and clinical trials focusing on the prevention and management of myopia progression in children. Submissions should address key themes such as the long-term efficacy and safety of interventions, the role of genetic and environmental factors, and the public health implications of rising myopia rates. We also welcome papers discussing novel technologies and emerging trends in myopia management, aiming to provide a comprehensive understanding of the current landscape and future directions for tackling this public health issue.
The primary aim of this research topic is to address the growing challenge of childhood myopia and evaluate the efficacy of interventional modalities for both prevention and management. The goal is to gather high-quality research that presents novel strategies for controlling myopia progression, with a focus on interventions that can be implemented in early childhood. This includes evaluating various optical, pharmacological, and behavioural interventions, assessing their long-term impact, and understanding their potential in clinical practice. By examining these interventional strategies, this research hopes to provide clearer guidelines for healthcare professionals and policymakers to implement effective programs that reduce the prevalence and complications associated with childhood myopia. Ultimately, the aim is to contribute towards developing a more targeted and multidisciplinary approach to controlling the global myopia epidemic.
The scope of this research topic includes a wide range of interventional approaches for childhood myopia. We invite submissions that explore therapeutic modalities, including pharmacological treatments such as atropine eye drops; optical interventions like specialised spectacles, contact lenses, orthokeratology lenses and environmental strategies such as increased outdoor activity. Authors are encouraged to submit original research, reviews, meta-analyses, case reports and clinical trials focusing on the prevention and management of myopia progression in children. Submissions should address key themes such as the long-term efficacy and safety of interventions, the role of genetic and environmental factors, and the public health implications of rising myopia rates. We also welcome papers discussing novel technologies and emerging trends in myopia management, aiming to provide a comprehensive understanding of the current landscape and future directions for tackling this public health issue.
Keywords: myopia, myopia progression, myopia prevention, childhood myopia, myopia interventions
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
